Razvan L Cornea

Author PubWeight™ 13.89^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on Ca sparks.	Circ Res	2010	2.29
2	Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants.	Circ Res	2014	1.27
3	Defining the molecular components of calcium transport regulation in a reconstituted membrane system.	Biochemistry	2003	1.14
4	Close proximity between residue 30 of phospholamban and cysteine 318 of the cardiac Ca2+ pump revealed by intermolecular thiol cross-linking.	J Biol Chem	2002	1.07
5	Functional and physical competition between phospholamban and its mutants provides insight into the molecular mechanism of gene therapy for heart failure.	Biochem Biophys Res Commun	2011	1.03
6	FRET detection of calmodulin binding to the cardiac RyR2 calcium release channel.	Biophys J	2011	1.00
7	Cardiac myocyte Z-line calmodulin is mainly RyR2-bound, and reduction is arrhythmogenic and occurs in heart failure.	Circ Res	2013	0.98
8	Discovery of enzyme modulators via high-throughput time-resolved FRET in living cells.	J Biomol Screen	2014	0.97
9	Calmodulin oxidation and methionine to glutamine substitutions reveal methionine residues critical for functional interaction with ryanodine receptor-1.	J Biol Chem	2003	0.90
10	Direct detection of calmodulin tuning by ryanodine receptor channel targets using a Ca2+-sensitive acrylodan-labeled calmodulin.	Biochemistry	2005	0.90
11	N-terminal and central segments of the type 1 ryanodine receptor mediate its interaction with FK506-binding proteins.	J Biol Chem	2013	0.87
12	In cardiomyocytes, binding of unzipping peptide activates ryanodine receptor 2 and reciprocally inhibits calmodulin binding.	Circ Res	2012	0.84
13	A novel SERCA inhibitor demonstrates synergy with classic SERCA inhibitors and targets multidrug-resistant AML.	Mol Pharm	2013	0.78